<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04929873</url>
  </required_header>
  <id_info>
    <org_study_id>2020-567</org_study_id>
    <nct_id>NCT04929873</nct_id>
  </id_info>
  <brief_title>Clinical Study of VA-ECMO Remote Limb Re-perfusion Monitoring Technology</brief_title>
  <official_title>Clinical Study of VA-ECMO Remote Limb Re-perfusion Monitoring Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Establish and verify the feasibility and effectiveness of VA-ECMO remote limb re-perfusion&#xD;
      monitoring technology.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is proposed to monitor VA-ECMO arterial end side branch circulation in real time through a&#xD;
      set of monitoring equipment, guide clinical adjustment, improve lower limb re-perfusion,&#xD;
      reduce the occurrence of lower limb ischemia, in order to achieve the goal of early&#xD;
      detection, early prevention and early treatment, and provide reference and theoretical basis&#xD;
      for clinical practice.&#xD;
&#xD;
      Monitoring techniques are divided into two parts: A. monitoring equipment (connecting&#xD;
      transdiotic monitoring pressure on va-ECMO side branches cycle); B.to guide clinical&#xD;
      adjustment by monitoring pressure (average arterial pressure).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>transdynation for real-time pressure monitoring</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of ischemia Incidence of ischemia</measure>
    <time_frame>1 year</time_frame>
    <description>of ischemia in the lower extremities on the side of the tube</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Perfusion; Complications</condition>
  <arm_group>
    <arm_group_label>routine treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>routine nursing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Immediately after the establishment of the side branch cycle, the closed transdone is connected for real-time monitoring of pressure, and clinical nursing practice is guided by transdictor pressure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Closed transdyser</intervention_name>
    <description>When the average arterial pressure ≥ 50mmHg, it is indicated that the basic blood supply of the lower extremities is satisfied without special treatment, and when the average arterial pressure &lt; 50mmHg, it indicates insufficient perfusion, by adjusting the pipe position, changing the ECMO flow rate, and properly clamping the artery end to divert part of the blood flow to the side branch circulation, so that the average arterial pressure is maintained above 50mmHg.</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Routine monitor</intervention_name>
    <description>Obtain oxygen saturation, skin color, temperature, etc</description>
    <arm_group_label>routine treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: adult patients ≥ 18 years of age;&#xD;
&#xD;
          -  signed ECMO informed consent;&#xD;
&#xD;
          -  femur vein VA-ECMO treatment;&#xD;
&#xD;
          -  agreed to establish VA-ECMO side branch cycle;&#xD;
&#xD;
          -  informed consent to this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  a completely closed double lower limb venously before surgery;&#xD;
&#xD;
          -  amputee&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fei Zeng</last_name>
    <role>Study Chair</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fei Zeng</last_name>
    <phone>13757119536</phone>
    <email>zengfei@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>SAHZhejiangU</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Zeng</last_name>
      <phone>13757119536</phone>
      <email>zengfei@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

